World's Best Scientists 2026 revealed!
James Tartaglia

James Tartaglia

D-Index & Metrics

Immunology

D-Index
73
Citations
16668
World Ranking
2153
National Ranking
85

Overview

James Tartaglia is affiliated with Sanofi in France and has contributed to research primarily in the fields of Immunology and Microbiology, with a strong focus on Medicine. Their work spans various subfields including Virology, Molecular Biology, Infectious Diseases, Immunology, and Epidemiology.

The scientist's research topics encompass HIV Research and Treatment, HIV/AIDS Research and Interventions, vaccines and immunoinformatics approaches, Immune Cell Function and Interaction, Poxvirus research and outbreaks, Bacillus and Francisella bacterial research, and Herpesvirus Infections and Treatments.

Recent papers authored or co-authored by James Tartaglia include:

  • Faculty Opinions recommendation of Broadly neutralizing antibody-derived CAR-T cells reduce viral reservoir in HIV-1-infected individuals., 2021, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk, 2022, The Journal of Infectious Diseases
  • Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial, 2020, The Lancet HIV
  • Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies, 2023, Vaccine
  • HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions, 2020, JCI Insight

The regular collaborators of James Tartaglia include Sorachai Nitayaphan, Faruk Sinangil, Nelson L. Michael, Merlin L. Robb, and Robert J. O'Connell, each having co-authored multiple publications with them.

James Tartaglia has published in venues such as Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, The Journal of Infectious Diseases, Vaccine, The Lancet HIV, and JCI Insight.

Best Publications

  • NYVAC: a highly attenuated strain of vaccinia virus

    James Tartaglia;Marion E. Perkus;Jill Taylor;Elizabeth K. Norton

  • Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

    Denis Gaucher;René Therrien;Nadia Kettaf;Bastian R. Angermann

  • Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination

    Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp

  • Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

    Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan

  • An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.

    Alexandre Harari;Pierre-Alexandre Bart;Wolfgang Stöhr;Gonzalo Tapia

  • Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

    David C. Montefiori;Chitraporn Karnasuta;Ying Huang;Hasan Ahmed

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon

    E. Beattie;J. Tartaglia;E. Paoletti

  • Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

    Elizabeth Beattie;Karen L. Denzler;James Tartaglia;Marion E. Perkus

  • TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR

    Heesung Park;Monique V. Davies;Jeffrey O. Langland;Hwai-Wen Chang

  • Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

    Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  • Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

    Merlin L Robb;Supachai Rerks-Ngarm;Sorachai Nitayaphan;Punnee Pitisuttithum

  • The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer

    Laszlo Radvanyi;Devender Singh-Sandhu;Scott Gallichan;Corey Lovitt

  • Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

    Raphael Gottardo;Robert T. Bailer;Bette T. Korber;S. Gnanakaran

  • A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers

    Thomas G. Evans;Michael C. Keefer;Kent J. Weinhold;Mark Wolff

  • The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

    Nicos Karasavvas;Erik Billings;Mangala Rao;Constance Williams

  • Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

    Robert B. Belshe;Geoffrey J. Gorse;Mark J. Mulligan;Thomas G. Evans

  • Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.

    Jill Taylor;Randall Weinberg;James Tartaglia;Christopher Richardson;Christopher Richardson

  • Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

    Zdenek Hel;Janos Nacsa;Elzbieta Tryniszewska;Wen-Po Tsai

  • Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

    Nicolas van Baren;Marie-Claude Bonnet;Brigitte Dréno;Amir Khammari

  • Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

    Zdenek Hel;David Venzon;Monita Poudyal;Wen Po Tsai

Frequent Co-Authors

Philippe Moingeon
Philippe Moingeon Sanofi (France)
Enzo Paoletti
Enzo Paoletti Rensselaer Polytechnic Institute
David C. Montefiori
David C. Montefiori Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University
Guido Ferrari
Guido Ferrari Duke University
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Punnee Pitisuttithum
Punnee Pitisuttithum Mahidol University
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Sorachai Nitayaphan
Sorachai Nitayaphan Armed Forces Research Institute of Medical Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare professions, many of which require specialized nursing education. For those interested in rapidly advancing their nursing career, exploring a 12-month accelerated nursing programs can be a practical option. These programs allow individuals with a prior degree to quickly earn a Bachelor of Science in Nursing (BSN) and enter the healthcare workforce efficiently.

Entry-level nursing roles also connect closely with immunology fields, especially in patient care and disease management. Students may consider applying to easy admission LPN programs as a straightforward pathway to becoming licensed practical nurses, which serve as essential healthcare providers in many settings.

For those interested in advanced clinical roles, knowing what is the easiest NP program helps prospective students identify flexible and accessible nurse practitioner degrees. This is particularly relevant for careers that integrate immunological expertise within patient treatment plans.

Additionally, specializing in mental health as a Psychiatric Mental Health Nurse Practitioner (PMHNP) can complement immunological knowledge, especially in managing psychosomatic and autoimmune disorders. Programs like top psychiatric mental health nurse practitioner programs online offer excellent clinical placement opportunities that blend theoretical learning with hands-on experience.

Best Scientists Citing James Tartaglia

Trending Scientists